Abstract
Safety and Efficacy of Combining Tagraxofusp (SL-401) with Azacitidine or Azacitidine and Venetoclax in a Phase 1b Study for CD123 Positive AML, MDS, or BPDCN
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have